In response to the increase in opioid overdose deaths in the United States, many states have implemented supply-controlling and harm-reduction policy measures aimed at reducing those deaths. But a recent study from Indiana ...
Feb 17, 2021
0
13
To cope with mental health conditions during the COVID-19 pandemic, people are increasingly turning to prescription drugs like antidepressants and benzodiazepines, which are commonly used as antianxiety medications.
Apr 28, 2020
0
10
A decision-support framework developed by management science researchers from The University of Texas at Dallas could help clinicians objectively identify and estimate harms and benefits of opioid use for pain management.
Apr 14, 2022
0
32
The COVID medication Paxlovid has been available in Australia on the Pharmaceuticals Benefits Scheme (PBS) since the start of May, with eligible patients directed to talk to their GP for a prescription.
May 27, 2022
0
4
Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.
Mar 31, 2022
0
2
Smoking-cessation drugs prescribed exclusively over the internet in a clinical trial were as safe and effective as when prescribed in a clinician's office, according to a newly published CAMH study in the journal Drug and ...
Feb 9, 2022
0
6
A review of 922 prescription medications taken by almost 150 million people over an 11-year period shows that just 10 of these drugs were associated with an increased rate of suicide attempts. Forty-four drugs were linked ...
Nov 5, 2019
0
303
Nearly half of people in a large U.S. study reported misusing prescription drugs between ages 18-50, which made them more likely to develop substance use disorder symptoms as adults––especially those whose misuse peaked ...
Jan 4, 2022
0
37
After reviewing tens of millions of insurance claims for the country's 49 most popular brand-name prescription drugs, a team from Scripps Research Translational Institute found that net prices rose by a median of 76 percent ...
May 31, 2019
4
99
The prevalence rate of prescriptions for benzodiazepines and benzodiazepine-related drugs (BZD)—medications used to treat anxiety, insomnia, epilepsy and other neuropsychiatric conditions—increased by 22% between 2006 ...
Aug 7, 2018
0
58
